Uscom Ltd (UCM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Uscom Ltd (UCM) has a cash flow conversion efficiency ratio of -7.065x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.29 Million ≈ $-913.86K USD) by net assets (AU$182.80K ≈ $129.34K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See UCM net asset quality score to measure how much of total assets are equity-financed.
Uscom Ltd - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Uscom Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Uscom Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Uscom Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Uscom Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Divio Technologies AB Series B
ST:DIVIO-B
|
0.255x |
|
Healthcare Triangle Inc
NASDAQ:HCTI
|
-0.132x |
|
R&R Real Estate Investment Trust
V:RRR-UN
|
-0.038x |
|
Cell Impact AB
ST:CI
|
-0.104x |
|
Grand Gulf Energy Ltd
AU:GGE
|
-0.003x |
|
Oryx International Growth Fund
LSE:OIG
|
0.003x |
|
Brown Advisory US Smaller Companies PLC
LSE:BASC
|
-0.002x |
|
CCSC Technology International Holdings Limited Ordinary Shares
NASDAQ:CCTG
|
-0.041x |
Annual Cash Flow Conversion Efficiency for Uscom Ltd (2005–2025)
The table below shows the annual cash flow conversion efficiency of Uscom Ltd from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see Uscom Ltd (UCM) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$-38.22K ≈ $-27.05K |
AU$-2.71 Million ≈ $-1.92 Million |
70.897x | +18753.99% |
| 2024-06-30 | AU$3.06 Million ≈ $2.17 Million |
AU$-1.16 Million ≈ $-823.17K |
-0.380x | +18.76% |
| 2023-06-30 | AU$3.04 Million ≈ $2.15 Million |
AU$-1.42 Million ≈ $-1.01 Million |
-0.468x | -186.98% |
| 2022-06-30 | AU$5.94 Million ≈ $4.20 Million |
AU$-967.51K ≈ $-684.58K |
-0.163x | -1012.52% |
| 2021-06-30 | AU$3.08 Million ≈ $2.18 Million |
AU$54.98K ≈ $38.90K |
0.018x | +121.59% |
| 2020-06-30 | AU$3.42 Million ≈ $2.42 Million |
AU$-283.23K ≈ $-200.40K |
-0.083x | +76.33% |
| 2019-06-30 | AU$3.49 Million ≈ $2.47 Million |
AU$-1.22 Million ≈ $-862.86K |
-0.350x | +0.16% |
| 2018-06-30 | AU$4.84 Million ≈ $3.43 Million |
AU$-1.70 Million ≈ $-1.20 Million |
-0.350x | -38.97% |
| 2017-06-30 | AU$3.78 Million ≈ $2.67 Million |
AU$-952.04K ≈ $-673.63K |
-0.252x | +3.60% |
| 2016-06-30 | AU$4.94 Million ≈ $3.49 Million |
AU$-1.29 Million ≈ $-913.32K |
-0.261x | +39.74% |
| 2015-06-30 | AU$2.29 Million ≈ $1.62 Million |
AU$-992.80K ≈ $-702.47K |
-0.434x | -16.52% |
| 2014-06-30 | AU$3.32 Million ≈ $2.35 Million |
AU$-1.24 Million ≈ $-874.36K |
-0.372x | +9.78% |
| 2013-06-30 | AU$2.35 Million ≈ $1.67 Million |
AU$-971.58K ≈ $-687.45K |
-0.413x | +63.38% |
| 2012-06-30 | AU$1.47 Million ≈ $1.04 Million |
AU$-1.66 Million ≈ $-1.17 Million |
-1.127x | -60.99% |
| 2011-06-30 | AU$3.14 Million ≈ $2.22 Million |
AU$-2.19 Million ≈ $-1.55 Million |
-0.700x | -14.47% |
| 2010-06-30 | AU$2.45 Million ≈ $1.73 Million |
AU$-1.50 Million ≈ $-1.06 Million |
-0.611x | -83.86% |
| 2009-06-30 | AU$3.06 Million ≈ $2.16 Million |
AU$-1.02 Million ≈ $-719.05K |
-0.333x | +32.24% |
| 2008-06-30 | AU$3.41 Million ≈ $2.41 Million |
AU$-1.67 Million ≈ $-1.18 Million |
-0.491x | +17.42% |
| 2007-06-30 | AU$5.50 Million ≈ $3.89 Million |
AU$-3.27 Million ≈ $-2.31 Million |
-0.594x | -58.62% |
| 2006-06-30 | AU$8.51 Million ≈ $6.02 Million |
AU$-3.19 Million ≈ $-2.26 Million |
-0.375x | -70.02% |
| 2005-06-30 | AU$11.75 Million ≈ $8.31 Million |
AU$-2.59 Million ≈ $-1.83 Million |
-0.220x | -- |
About Uscom Ltd
Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices in Australia, Asia, the Americas, and Europe. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures blood flow, stroke volume, and cardiac output; and BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure w… Read more